DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	LILRA1; F2; PRL; IFNG; IL2RA; CD3D; INHBA; CD3G; CCL2; CXCR1; LAMA1; GLP1R; CXCR3; CCR5; ADGRE1; LILRB2; ADGRE3; CLEC1B; CLEC4A; TRBV24-1; TRBV6-4; TRBV19; TRBV6-6; TRBV5-1; TRBV6-1; TRBV7-1; TRBV27; TRBV6-8; TRBV17; TRBV5-5; TRBV3-1; TRBV2; TRBV13; TRBV28; TRBV6-2; TRBV11-1; TRBV25-1; TRBV7-2; TRBV4-1; TRBV11-3; TRBV7-6; TRBV29-1; TRBV10-1; TRBV7-7; TRBV14; TRBV15; TRBV5-7; TRBV30; TRBV6-7; TRBV4-2; TRBV20-1; TRBV7-4; TRBV12-5; TRBV6-5; TRBV12-4; TRBV5-6; TRBV16; TRBV23-1; TRBV5-4; TRBV9; TRBV12-3; TRBV18; TRBV7-9; TRBV11-2; PDCD1LG2; TRBV10-3;	GO:0007166~cell surface receptor signaling pathway	66	268	24.6268656716418	0	0	0	0	0	0	0
down	EVPLL; FOXN1; TGM5; KRT34; SCEL; GJB5; KRT14; FGF7; SPRR1B; SPRR2E; SPRR2D; S100A7; CASP14; NTF4; SPRR1A; SPRR2B; SPRR2A; KLK7; EMP1; ELF3; FABP5; BNC1; KRT32; KRT31; CST6; CERS3; ACER1; GRHL3; HOXB13; SPRR2F; SPRR2G; GRHL1; CALML5; SPRR3; KLK5; KRTDAP;	GO:0008544~epidermis development	36	82	43.9024390243902	0	0	0	0	0	0	0
down	MT1A; MT1E; MT1B; MT1G; MT1H; MT1X; PTK6; MT1M;	GO:0045926~negative regulation of growth	8	18	44.4444444444444	0.00010115757215745	0.0232012117283982	0.323501915759528	0.324816964197575	0.322894970326583	0.323501915759528	0.200730133844399
down	FGF10; RAMP3; MIF; PDGFRA; ADCYAP1; FGFR3; FSHR; S100A7; FLT4; KDR; CHRNA7; PLA2G5; CASR; CX3CL1; GPNMB; ANGPT1; SYT14P1; TNFAIP8L3; FFAR4; NPNT; SLC30A10; CCL19; GAREM1; NOX4; CCL11; CCL1; CCL17; HMGB1P1; CCL14; CCL18;	GO:0070374~positive regulation of ERK1 and ERK2 cascade	30	209	14.3540669856459	0.00012249130944153	0.0250431305556245	0.391604716284572	0.393319594616754	0.390869768427923	0.391604716284572	0.216665879660085
down	CXCL11; WNT9B; CXCL13; CXCL14; POMC; C1QA; INHA; PGR; S100A9; GJB1; CGB7; EDN3; GJA1; ADCYAP1; NTF3; FGFR3; GJB2; CCL18; CX3CL1; CXCL9; IL18; GPNMB; CCL17; TFAP2C; FGF14; TBX5; STAB1; IL36G; DRD1; ADRA2C; ADRA2A; FGFBP1;	GO:0007267~cell-cell signaling	32	230	13.9130434782609	0.00012478669850202	0.0250431305556245	0.398818288412462	0.400690088889992	0.398194354919952	0.398818288412462	0.216665879660085
up	OR2A1; P2RY10; FCN1; GPR171; RGS13; OR2H2; F2; CALCA; GHRH; PF4; OPN1SW; CALCB; PTHLH; TRH; HRH2; CXCR1; ADRA1D; CXCR5; SSTR3; CNR2; TRHR; OPRM1; GLP1R; CCR10; CXCR3; GPR15; CCR5; CCR6; NLRP6; RGS1; PTGDR; ADGRE1; OR2B11; OR2T2; TAS2R42; OR2W3; GPR65; OR2L5; OR2AK2; OR2L3; OR10G2; OR2D3; OR56B2P; OR52N4; OR56B1; OR52I1; OR9A4; GPR150; OR2T34; OR2L8; OR2T10; OR2T3; OR2L2; OR52I2; RXFP2; RLN3; PIK3R5; NPY6R; ADGRE3; OR10A2; OR10A4; PROK2; CYSLTR2; GNG8; GPR55; OR4D1; OR4E2; OR1F1; OR1F2P; OR4E1; CCL26; CCL2; OR3A1; MRGPRD; GNG10; OR5K2; OR3A4P; OR5B21; CCL7; CCL24; OR5K1;	GO:0007186~G protein-coupled receptor signaling pathway	81	1152	7.03125	0.00020661580038949	0.0723306496790609	0.394842794544331	0.395669257745889	0.394429562943552	0.394842794544331	0.588406192596446
down	CLDN5; CLDN7; CLDN1; CLDN8; CLDN17; CLDN18; CLDN2; CLDN10;	GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	8	21	38.0952380952381	0.00023624679281864	0.0446228501023913	0.754808503055553	0.758588451740652	0.68417071200278	0.754808503055553	0.386063916765522
down	UGT1A9; UGT1A1; UGT1A7; UGT1A10; UGT1A8;	GO:0051552~flavone metabolic process	5	6	83.3333333333333	0.00026956225110208	0.0480869104604885	0.860981830020058	0.865564388288793	0.733748447499874	0.860981830020058	0.416033959169593
down	MT1X; MT1E; MT1B; MT1A; MT1H; MT1M; MT1G;	GO:0010273~detoxification of copper ion	7	16	43.75	0.00029851196145747	0.0504485214863125	0.953148692933703	0.958521908239938	0.774189603050812	0.953148692933703	0.436465930691228
down	CYP1A1; MT1G; AQP1; MT1X; MT1B; MT1A; MT1M; MT1H; MT1E;	GO:0071280~cellular response to copper ion	9	29	31.0344827586207	0.00034270736410213	0.0526055364231192	1	1	0.830722650583575	0.999999778582005	0.455127796374719
down	CD1A; CD1C; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	4	5	80	0.00129875725030471	0.147678898846592	1	1	0.999999778582005	0.999999778582005	1
down	GJB5; GJB1; GJA1; GJB2;	GO:1905867~epididymis development	4	5	80	0.00129875725030471	0.147678898846592	1	1	0.999999778582005	0.999999778582005	1
down	A2ML1; CSTA; CSTB; SPINK8; SERPINB3; SPINK7; WFDC2; CST6; CST9; ITIH5; WFDC5; WFDC12; CSTL1; SERPINB13; SERPINI2; SERPINB7; SERPINB4; SERPINA11; SERPINB12; SERPINB5; SERPINB11;	GO:0010951~negative regulation of endopeptidase activity	21	148	14.1891891891892	0.00134665849139526	0.147678898846592	1	1	0.999999778582005	0.999999778582005	1
down	FGF10; GJB6; CLDN1; REN; PENK; CYP1A1; S100A8; SCGB1A1; SELE; GJA1; UGT1A1; GJB2; S100A7; PTGER1; PCK1; BDKRB1; S100A14; GNG12; GGT5; NOS2;	GO:0032496~response to lipopolysaccharide	20	138	14.4927536231884	0.00137974679707187	0.147678898846592	1	1	0.999999778582005	0.999999778582005	1
up	TYROBP; NCR1; MNDA; KIR3DL2; CCR5; CCR6; TRAT1; LILRB2; KIR2DL4;	GO:0006968~cellular defense response	9	53	16.9811320754717	0.00142310282087954	0.320160348120974	1	1	0.999999999950212	0.999999999950211	1
down	CYP1A1; CYP2C9; CYP2C19; CYP4A11; CYP4A22;	GO:0097267~omega-hydroxylase P450 pathway	5	10	50	0.00142963655771433	0.148082676994217	1	1	0.999999778582005	0.999999778582005	1
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.00150467004338839	0.320160348120974	1	1	0.999999999950212	0.999999999950211	1
up	TYROBP; CTLA4; IL10; MNDA; CD300A;	GO:0030889~negative regulation of B cell proliferation	5	16	31.25	0.00178775184809155	0.342354478909531	1	1	0.999999999950212	0.999999999950211	1
down	CD5L; S100A8; S100A9; KRT16; MIF; SELE; FCGR2B; BDKRB1; CSRP3; CARD18; ELF3; MS4A2; IL18; ECM1; TRIL; NLRP10; IL17F; CCL19; RARRES2; IL1RL2; CYP4F11; NOX4; STAB1; CCL11; IL36A; ACKR1; CCL1; CXCL13; CCL17; PTGER1; CCL14; GPR33; CXCL9; IL36G; IL36RN; CCL18; IL1F10; IL36B; CX3CL1; CXCL11; GGT5;	GO:0006954~inflammatory response	41	381	10.761154855643	0.00193275580255636	0.188062996424499	1	1	0.999999778582005	0.999999778582005	1
down	TCF21; ID1; FOXF1; STRA6;	GO:0060426~lung vasculature development	4	6	66.6666666666667	0.00206143707077378	0.194684542183959	1	1	0.999999778582005	0.999999778582005	1
down	MPZL2; CDH16; CEACAM5; DSG3; DSG1; CADM3; ROBO2; CDH22; PCDHB8; PCDHB10; PCDHGB4; PCDHA7; PCDHA4; PCDHB5; PCDHGC4; PCDHA9; NECTIN4; CNTN4; VSTM2L; CDH19; IGSF21; CDH12;	GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules	22	165	13.3333333333333	0.00212859153875156	0.195283069455179	1	1	0.999999778582005	0.999999778582005	1
down	CYP1A1; ADH1A; CYP2C9; UGT1A1; CYP2C19; FMO2; UGT1A7;	GO:0017144~drug metabolic process	7	25	28	0.00254301527623324	0.220692487891485	1	1	0.999999778582005	0.999999778582005	1
down	MT1A; MT1E; MT1B; MT1G; MT1H; MT1X; MT1M;	GO:0071294~cellular response to zinc ion	7	25	28	0.00254301527623324	0.220692487891485	1	1	0.999999778582005	0.999999778582005	1
down	APOA1; APOC1; APOC3; APOA4; ABCA12;	GO:0033700~phospholipid efflux	5	12	41.6666666666667	0.00266238983569145	0.224971941115927	1	1	0.999999778582005	0.999999778582005	1
down	SAA1; CX3CL1; CCL18; CCL1; CCL14; CCL19; CCL17; CCL11;	GO:0048247~lymphocyte chemotaxis	8	33	24.2424242424242	0.00275805876508728	0.227080171658853	1	1	0.999999778582005	0.999999778582005	1
down	CXCL13; S100A8; GJA1; CCL11;	GO:0002544~chronic inflammatory response	4	7	57.1428571428571	0.00308536553911742	0.235883541573954	1	1	0.999999778582005	0.999999778582005	1
down	S100A8; SERPINB3; CX3CL1; HILPDA;	GO:0035425~autocrine signaling	4	7	57.1428571428571	0.00308536553911742	0.235883541573954	1	1	0.999999778582005	0.999999778582005	1
down	CD1C; CD1A; CD1B; CD1E;	GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib	4	7	57.1428571428571	0.00308536553911742	0.235883541573954	1	1	0.999999778582005	0.999999778582005	1
down	APOA1; APOC3; HNF4A; IL18; GCKR; GPIHBP1; APOA4;	GO:0070328~triglyceride homeostasis	7	27	25.9259259259259	0.00365788188982463	0.260390087045127	1	1	0.999999778582005	0.999999778582005	1
down	PGC; KLK7; KLK5;	GO:0002803~positive regulation of antibacterial peptide production	3	3	100	0.00381137779231422	0.260390087045127	1	1	0.999999778582005	0.999999778582005	1
down	TGM1; TGM3; HRNR;	GO:0043163~cell envelope organization	3	3	100	0.00381137779231422	0.260390087045127	1	1	0.999999778582005	0.999999778582005	1
up	CNR2; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.0039441011368998	0.609060813203013	1	1	0.999999999950212	0.999999999950211	1
down	FGF10; GLI2; FGF7; KRT17; TGM3; SOSTDC1; FOXQ1;	GO:0031069~hair follicle morphogenesis	7	28	25	0.00433802784318438	0.274028390076113	1	1	0.999999778582005	0.999999778582005	1
down	GJB6; GJB1; GJA1; GJB2;	GO:0016264~gap junction assembly	4	8	50	0.0044084796062257	0.274028390076113	1	1	0.999999778582005	0.999999778582005	1
down	C1QA; C1QB; C1QC; CX3CL1;	GO:0098883~synapse pruning	4	8	50	0.0044084796062257	0.274028390076113	1	1	0.999999778582005	0.999999778582005	1
down	SAA1; EDN2; EDNRB; CX3CL1; CXCL17;	GO:0048246~macrophage chemotaxis	5	14	35.7142857142857	0.00452304723576269	0.274028390076113	1	1	0.999999778582005	0.999999778582005	1
down	SCNN1A; SCNN1B; SCNN1G; CYP4A11; TFAP2B;	GO:0055078~sodium ion homeostasis	5	14	35.7142857142857	0.00452304723576269	0.274028390076113	1	1	0.999999778582005	0.999999778582005	1
down	CYP1A1; CYP2C9; CYP2C19; CYP4A11; CYP2F1; CYP2C18;	GO:0019373~epoxygenase P450 pathway	6	21	28.5714285714286	0.0047139269351798	0.28030406275671	1	1	0.999999778582005	0.999999778582005	1
up	OR2A1; OR5B21; OR1F1; OR2H2; OR4E1; OR3A1; OR3A4P; OR4D1; OR2B11; OR2T2; OR2W3; OR2L5; OR2AK2; OR2L3; OR4E2; OR10G2; OR2D3; OR56B2P; OR52N4; OR56B1; OR52I1; OR9A4; OR2T34; OR2L8; OR2T10; OR2T3; OR2L2; OR52I2; OR5K1; OR5K2; OR1F2P; OR10A2; OR10A4;	GO:0050911~detection of chemical stimulus involved in sensory perception of smell	33	435	7.58620689655172	0.00516345578880995	0.609060813203013	1	1	0.999999999950212	0.999999999950211	1
up	TRGV2; TRGV5; TRGV8; TRGV4; TRDV1; TRDV2; LILRA5; CD300LB; TYROBP; LY86; TRGV3; DEFA4; KIR2DS4; NLRP6; LILRA4; SIGLEC14; SLAMF1; CD300E; CLEC6A; TREML4; NLRP9; LILRA2; CLEC4C; PGLYRP2; CD180; TRGV9; TLR8; CD84; CLEC4A; TRDC; IGHV3-35; TRBC1; TRBC2; IGHV3-13; BPI; IGHV4-34; IGHD;	GO:0045087~innate immune response	37	505	7.32673267326733	0.00540147543968328	0.609060813203013	1	1	0.999999999950212	0.999999999950211	1
up	LILRA5; IFNG; ORM1; ORM2; LILRA2;	GO:1904469~positive regulation of tumor necrosis factor secretion	5	22	22.7272727272727	0.00570784837546512	0.609060813203013	1	1	0.999999999950212	0.999999999950211	1
up	CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	3	6	50	0.00572485359668629	0.609060813203013	1	1	0.999999999950212	0.999999999950211	1
up	APOA2; IL10; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	3	6	50	0.00572485359668629	0.609060813203013	1	1	0.999999999950212	0.999999999950211	1
down	ADCYAP1; ADCYAP1R1; SCTR; FFAR4; GPR62;	GO:0043950~positive regulation of cAMP-mediated signaling	5	15	33.3333333333333	0.00573496626565839	0.328838869268377	1	1	0.999999778582005	0.999999778582005	1
down	MT1X; MT1A; MT1H; MT1E; MT1B; MT1G; MT1M;	GO:0006882~cellular zinc ion homeostasis	7	30	23.3333333333333	0.0059794906552344	0.329981019882961	1	1	0.999999778582005	0.999999778582005	1
down	APOA1; APOC3; APOA4; GPIHBP1;	GO:0034371~chylomicron remodeling	4	9	44.4444444444444	0.00606638812329408	0.329981019882961	1	1	0.999999778582005	0.999999778582005	1
down	SPDEF; SOSTDC1; NKX6-2;	GO:0010454~negative regulation of cell fate commitment	3	4	75	0.00637148029671242	0.329981019882961	1	1	0.999999778582005	0.999999778582005	1
down	EDN3; EDN2; EDNRB;	GO:0014826~vein smooth muscle contraction	3	4	75	0.00637148029671242	0.329981019882961	1	1	0.999999778582005	0.999999778582005	1
down	CIDEA; APOA4; LY6D;	GO:0035634~response to stilbenoid	3	4	75	0.00637148029671242	0.329981019882961	1	1	0.999999778582005	0.999999778582005	1
down	PTN; CHRNA7; ZNF365;	GO:0140059~dendrite arborization	3	4	75	0.00637148029671242	0.329981019882961	1	1	0.999999778582005	0.999999778582005	1
up	HBG1; HBG2; HBM; CYGB;	GO:0015671~oxygen transport	4	14	28.5714285714286	0.00678116426339437	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
down	GLI2; HOXB1; BMP5; SOSTDC1; GRHL3; FOXJ1; TBX5;	GO:0007389~pattern specification process	7	31	22.5806451612903	0.00695537980664496	0.354503564430745	1	1	0.999999778582005	0.999999778582005	1
up	CCL24; GHRH; WNT1; INHBA; PTHLH; GATA1; TRH; SSTR3; FASLG; CCR5; CCL7; CRB1; GRAP; LILRB2; FCRL2; IL26; SIRPG; CCL26; ADRA1D; FGFBP2;	GO:0007267~cell-cell signaling	20	230	8.69565217391304	0.00712662152394894	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
down	CSTA; CSTB; SERPINB3; SERPINB4; ECM1;	GO:0010466~negative regulation of peptidase activity	5	16	31.25	0.00715864458332538	0.359162621204028	1	1	0.999999778582005	0.999999778582005	1
up	PF4; IL10; CXCR5; CNR2; PF4V1;	GO:0030595~leukocyte chemotaxis	5	24	20.8333333333333	0.00781282816835671	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
down	IGF1; FGF1; ADRA2A; ADRA2C; NTF3; IL18; DYNAP;	GO:0032148~activation of protein kinase B activity	7	32	21.875	0.00804448274141145	0.397397447425726	1	1	0.999999778582005	0.999999778582005	1
up	ACOD1; LILRA1; OR2H2; INHBA; CD48; LILRA2; IL31RA; CLEC1B; CD84;	GO:0006952~defense response	9	72	12.5	0.00876861732532808	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
down	IL20RB; IL36A; IL36RN; IL1F10; IL36G; IL36B;	GO:0002437~inflammatory response to antigenic stimulus	6	25	24	0.00954471128506262	0.453250565357397	1	1	0.999999778582005	0.999999778582005	1
down	APOC1; APOC3; CCDC3;	GO:0045833~negative regulation of lipid metabolic process	3	5	60	0.00973973497653702	0.453250565357397	1	1	0.999999778582005	0.999999778582005	1
down	POMC; GCGR; PHLDA2;	GO:0070873~regulation of glycogen metabolic process	3	5	60	0.00973973497653702	0.453250565357397	1	1	0.999999778582005	0.999999778582005	1
down	FOXF1; TFAP2B; STRA6;	GO:0097070~ductus arteriosus closure	3	5	60	0.00973973497653702	0.453250565357397	1	1	0.999999778582005	0.999999778582005	1
down	S100A8; S100A9; SELE; CX3CL1;	GO:0002523~leukocyte migration involved in inflammatory response	4	11	36.3636363636364	0.0105144981865573	0.471084719470819	1	1	0.999999778582005	0.999999778582005	1
down	TCF21; PGR; EDN2; FLT4; FOXF1; ABCA12; STRA6;	GO:0048286~lung alveolus development	7	34	20.5882352941176	0.010591540437185	0.471084719470819	1	1	0.999999778582005	0.999999778582005	1
down	PLA2G5; PLA2G4F; PLA2G4D; PLA2G2F; PLA2G3;	GO:0036148~phosphatidylglycerol acyl-chain remodeling	5	18	27.7777777777778	0.0107098052075272	0.471084719470819	1	1	0.999999778582005	0.999999778582005	1
down	FGF10; TCF21; PDGFRA; FOXF1; OVOL2;	GO:0048557~embryonic digestive tract morphogenesis	5	18	27.7777777777778	0.0107098052075272	0.471084719470819	1	1	0.999999778582005	0.999999778582005	1
down	PLA2G5; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F; PLA2G3;	GO:0036152~phosphatidylethanolamine acyl-chain remodeling	6	26	23.0769230769231	0.0111604872870837	0.484274657821972	1	1	0.999999778582005	0.999999778582005	1
up	F2; F11; GP9; GP5;	GO:0007597~blood coagulation, intrinsic pathway	4	17	23.5294117647059	0.0119538942129163	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
down	GABRD; ADCYAP1; GABRB2; GRIK3; FGF14; GABRG3; GABRA4;	GO:0060078~regulation of postsynaptic membrane potential	7	35	20	0.0120639151584644	0.511276910374388	1	1	0.999999778582005	0.999999778582005	1
down	SULT2B1; CYP1A1; CYP2C9; UGT1A1; CYP2C19; AKR1C2; UGT1A8; DHCR24;	GO:0008202~steroid metabolic process	8	44	18.1818181818182	0.0121012286479145	0.511276910374388	1	1	0.999999778582005	0.999999778582005	1
down	ALOX12B; PSAPL1; SPNS2; ACER1; ALOXE3;	GO:0006665~sphingolipid metabolic process	5	19	26.3157894736842	0.0128694823134627	0.516775674931184	1	1	0.999999778582005	0.999999778582005	1
down	PLA2G5; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F;	GO:0036149~phosphatidylinositol acyl-chain remodeling	5	19	26.3157894736842	0.0128694823134627	0.516775674931184	1	1	0.999999778582005	0.999999778582005	1
down	APOC1; APOC3; NPC1L1; APOA4; APOA1;	GO:0042157~lipoprotein metabolic process	5	19	26.3157894736842	0.0128694823134627	0.516775674931184	1	1	0.999999778582005	0.999999778582005	1
down	PLA2G5; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F; PLA2G3;	GO:0036151~phosphatidylcholine acyl-chain remodeling	6	27	22.2222222222222	0.0129601768957162	0.516775674931184	1	1	0.999999778582005	0.999999778582005	1
down	REN; CPA3; CMA1; ACE2;	GO:0002003~angiotensin maturation	4	12	33.3333333333333	0.013360402584539	0.516775674931184	1	1	0.999999778582005	0.999999778582005	1
down	ADH1B; ADH1C; ADH1A; ADH7;	GO:0006069~ethanol oxidation	4	12	33.3333333333333	0.013360402584539	0.516775674931184	1	1	0.999999778582005	0.999999778582005	1
down	CHST9; DIO2; CHST8; DUOX2;	GO:0042446~hormone biosynthetic process	4	12	33.3333333333333	0.013360402584539	0.516775674931184	1	1	0.999999778582005	0.999999778582005	1
down	CDH16; DSG1; CDH22; PCDHB10; PCDHGB4; PCDHB5; CDH12; CDH19;	GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	8	45	17.7777777777778	0.0135188902816006	0.516775674931184	1	1	0.999999778582005	0.999999778582005	1
up	FN1; INHBA; HMGA2; LAMB3; LAMA3;	GO:0035987~endodermal cell differentiation	5	28	17.8571428571429	0.0135271575696884	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
up	LY86; SCIMP; CD180;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	3	9	33.3333333333333	0.0135921701438892	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
up	IGHD; ORM1; ORM2;	GO:0050716~positive regulation of interleukin-1 secretion	3	9	33.3333333333333	0.0135921701438892	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
down	GJB6; GJA1; GJB2;	GO:0010644~cell communication by electrical coupling	3	6	50	0.0139602238396674	0.521235799408979	1	1	0.999999778582005	0.999999778582005	1
down	SERPINB7; LUM; CX3CL1;	GO:0032914~positive regulation of transforming growth factor beta1 production	3	6	50	0.0139602238396674	0.521235799408979	1	1	0.999999778582005	0.999999778582005	1
down	AKR1B15; PIR; AKR1B10; ALOX12B; ALDH1L1; BBOX1; CH25H; CYP1A1; LIPF; GSTA1; SOD3; CYP2C9; NQO1; GPX3; ALDH3A1; FMO3; CYP2C19; NOS2; ADH7; ALDH1A3; ALDH3B2; TDO2; AKR1C2; CYP4A11; CRYM; PTGR1; DHCR24; PTGIS; CYP4A22; TXNDC8; IYD; IDO2; CYP4X1; CYP4Z2P; SDR16C5; FADS6; SDR9C7; DIO2; COX4I2; RDH12; ALOXE3; CYP4F11; NOX4; DUOX2; STAB1; CYP39A1; CYP2F1; CYP2C18;	GO:0055114~oxidation-reduction process	48	526	9.1254752851711	0.0145159209779726	0.535754278853679	1	1	0.999999778582005	0.999999778582005	1
up	ORM1; BPI; IL10; NCKAP1L; SLAMF1;	GO:0032715~negative regulation of interleukin-6 production	5	29	17.2413793103448	0.0153024796497615	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
down	EDN3; EDN2; HRC; AVPR1A; NMU;	GO:0010460~positive regulation of heart rate	5	20	25	0.0153050297757793	0.546049451222526	1	1	0.999999778582005	0.999999778582005	1
down	PDGFRA; EPCAM; HNF4A; MESP1; SOX17;	GO:0023019~signal transduction involved in regulation of gene expression	5	20	25	0.0153050297757793	0.546049451222526	1	1	0.999999778582005	0.999999778582005	1
down	CLDN7; EPCAM; DUOXA2; CCL19; DUOX2;	GO:2000147~positive regulation of cell motility	5	20	25	0.0153050297757793	0.546049451222526	1	1	0.999999778582005	0.999999778582005	1
up	CLEC12B; LILRB1; KIR2DL4;	GO:0045953~negative regulation of natural killer cell mediated cytotoxicity	3	10	30	0.0171039031546029	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
down	CXCL11; DRD1; APLNR; BDKRB1; CX3CL1; CXCL9;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	6	29	20.6896551724138	0.0171498357529232	0.5706413442718	1	1	0.999999778582005	0.999999778582005	1
down	DAPL1; SRRM4; KRT6A; TFF1; INHA; FGF1; HIST1H1T; ANXA13; COL15A1; ADCYAP1R1; TPPP2; KRTDAP; BNC1; NHLH2; ANGPT1; ECSCR; ODF4; NKAPL; CXCL17; SPATA19; ACER1; ATOH8; RARRES2; THEG; SOX17; POU3F1; NKX2-8; FOXA1; FOXD4L3; SPINK6; FOXI2; ID1; HNF4A; SPDEF; NKX6-1; FOXD4; CCDC160; NKX6-2; FOXQ1; HNF4G; SRY; ELF5; PTK6; NKX2-3; DLX5; HES2; NKX1-2; ID4; ELF3; FOXD4L4; DLX3;	GO:0030154~cell differentiation	51	572	8.91608391608392	0.017379810861787	0.5706413442718	1	1	0.999999778582005	0.999999778582005	1
down	FMO2; CYP2F1; CYP2C19; CYP2C9; CYP2C18;	GO:0006082~organic acid metabolic process	5	21	23.8095238095238	0.0180298848355258	0.5706413442718	1	1	0.999999778582005	0.999999778582005	1
down	PLA2G5; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F;	GO:0036150~phosphatidylserine acyl-chain remodeling	5	21	23.8095238095238	0.0180298848355258	0.5706413442718	1	1	0.999999778582005	0.999999778582005	1
down	CYP1A1; UGT1A7; UGT1A8;	GO:0009804~coumarin metabolic process	3	7	42.8571428571429	0.0190597038835075	0.5706413442718	1	1	0.999999778582005	0.999999778582005	1
down	AQP1; SCTR; AQP4;	GO:0009992~cellular water homeostasis	3	7	42.8571428571429	0.0190597038835075	0.5706413442718	1	1	0.999999778582005	0.999999778582005	1
down	POMC; SCTR; HTR4;	GO:0032098~regulation of appetite	3	7	42.8571428571429	0.0190597038835075	0.5706413442718	1	1	0.999999778582005	0.999999778582005	1
down	IYD; DIO2; CRYM;	GO:0042403~thyroid hormone metabolic process	3	7	42.8571428571429	0.0190597038835075	0.5706413442718	1	1	0.999999778582005	0.999999778582005	1
down	NUPR1; IL33; IL18;	GO:0150078~positive regulation of neuroinflammatory response	3	7	42.8571428571429	0.0190597038835075	0.5706413442718	1	1	0.999999778582005	0.999999778582005	1
up	IL2RA; CTLA4; IL10; LILRB2; LILRB1; PDCD1LG2;	GO:0042130~negative regulation of T cell proliferation	6	43	13.953488372093	0.0193305464791735	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
down	MT1A; MT1E; MT1G; MT1H; MT1X; MT1M; MT1B;	GO:0071276~cellular response to cadmium ion	7	39	17.9487179487179	0.0194406675246991	0.5706413442718	1	1	0.999999778582005	0.999999778582005	1
down	KRT18; KRT16; KRT3; KRT6C; EVPLL;	GO:0045104~intermediate filament cytoskeleton organization	5	22	22.7272727272727	0.0210562389036822	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
up	LMOD3; LMOD2; SCIN;	GO:0045010~actin nucleation	3	11	27.2727272727273	0.0210731159627733	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
up	INHBA; ITGA3; HMGA2;	GO:0048333~mesodermal cell differentiation	3	11	27.2727272727273	0.0210731159627733	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
down	CLDN5; CHP2; CLDN7; VIP; KRT6A; S100B; IGF1; FGF1; ADRA2A; EDN3; PDGFRA; EPCAM; ADCYAP1; NTF3; EDN2; PTN; FGF7; BMP5; FGFR3; EDNRB; SERPINB3; ALDH3A1; FLT4; KDR; CHRNA7; AVPR1A; MYCNOS; CASR; ID4; AKR1C2; RAB25; CX3CL1; BNC1; MST1R; CCL14; EPGN; NCCRP1; DYNAP; TFAP2B; WWTR1; GAREM1; HILPDA; REG1A; PROK1;	GO:0008284~positive regulation of cell population proliferation	44	490	8.97959183673469	0.0231691865474746	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	CTSV; NRTN; NTF4; NTF3;	GO:0021675~nerve development	4	15	26.6666666666667	0.0246445226640026	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	SHISA9; UNC13B; GRIK2; SHISA6;	GO:0048172~regulation of short-term neuronal synaptic plasticity	4	15	26.6666666666667	0.0246445226640026	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	CIDEA; APOC1; APOC3; ADRA2A;	GO:0050995~negative regulation of lipid catabolic process	4	15	26.6666666666667	0.0246445226640026	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	SULT1C2; INMT; CYP1A1;	GO:0009308~amine metabolic process	3	8	37.5	0.0250500807626193	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	ADRA2A; ADRA2C; P2RY12;	GO:0010700~negative regulation of norepinephrine secretion	3	8	37.5	0.0250500807626193	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	APOA4; AADAC; APOA1;	GO:0010898~positive regulation of triglyceride catabolic process	3	8	37.5	0.0250500807626193	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	HOXD9; HOXD10; TFAP2B;	GO:0035137~hindlimb morphogenesis	3	8	37.5	0.0250500807626193	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	HOXB1; FOXA1; DLX5;	GO:0048646~anatomical structure formation involved in morphogenesis	3	8	37.5	0.0250500807626193	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	COBL; PLS3; PLS1;	GO:0051639~actin filament network formation	3	8	37.5	0.0250500807626193	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
up	LAMB3; LAMC2; LAMA3;	GO:0031581~hemidesmosome assembly	3	12	25	0.0255018855702778	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
up	IL10; SLAMF1; TIGIT;	GO:0032695~negative regulation of interleukin-12 production	3	12	25	0.0255018855702778	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
up	IL31; CD300LF; CTLA4; IRF8; IRF4;	GO:0002376~immune system process	5	35	14.2857142857143	0.0292313512173831	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
up	LILRA5; ORM1; ORM2; LILRA2; TLR8;	GO:0050718~positive regulation of interleukin-1 beta secretion	5	35	14.2857142857143	0.0292313512173831	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
down	MIF; EDN2; PTGIS; PLA2G4F;	GO:0001516~prostaglandin biosynthetic process	4	16	25	0.0293719117635617	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	ADRA2A; EDN3; EDN2; ACE2;	GO:0019229~regulation of vasoconstriction	4	16	25	0.0293719117635617	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	EDN3; EDN2; KEL; EDNRB;	GO:0042310~vasoconstriction	4	16	25	0.0293719117635617	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	GLI2; FOXF2; RARRES2; STRA6;	GO:0048566~embryonic digestive tract development	4	16	25	0.0293719117635617	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	SLC6A2; HAAO; CX3CL1; TYRO3;	GO:0070050~neuron cellular homeostasis	4	16	25	0.0293719117635617	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
up	NCKAP1L; CXCR1; PF4; CCL26; PF4V1; CCL24; CCL7; CCL2;	GO:0030593~neutrophil chemotaxis	8	76	10.5263157894737	0.0303211803276111	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
up	GHRH; WNT1; CDH3;	GO:0043568~positive regulation of insulin-like growth factor receptor signaling pathway	3	13	23.0769230769231	0.0303891135292755	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
down	OVOL1; TCF15; DHCR24; DACT2; ASCL4; TFAP2B;	GO:0043588~skin development	6	34	17.6470588235294	0.0314635497169968	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	HAAO; TDO2; IDO2;	GO:0006569~tryptophan catabolic process	3	9	33.3333333333333	0.0319306144814329	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	APOA1; APOC1; APOA4;	GO:0010873~positive regulation of cholesterol esterification	3	9	33.3333333333333	0.0319306144814329	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	FGF10; CLDN1; MMP12;	GO:0060054~positive regulation of epithelial cell proliferation involved in wound healing	3	9	33.3333333333333	0.0319306144814329	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	CTSV; GJA1; PTN; GJB2; PTGIS;	GO:0046697~decidualization	5	25	20	0.0320461367777548	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
up	PF4; IL10; IRF8; IRF4;	GO:0042832~defense response to protozoan	4	24	16.6666666666667	0.0321574109014656	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
up	ORM1; BPI; IL10; LILRA4; SLAMF1; CLEC4A;	GO:0032720~negative regulation of tumor necrosis factor production	6	49	12.2448979591837	0.0322109146420873	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
down	CX3CL1; CCL14; CCL18; CCL17; CCL19; CCL11; CCL1;	GO:0002548~monocyte chemotaxis	7	44	15.9090909090909	0.0324754607923647	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	HOXB1; PDGFRA; HOXD10; HOXD3; HOXD9; HOXD4; HOXC9;	GO:0048704~embryonic skeletal system morphogenesis	7	44	15.9090909090909	0.0324754607923647	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	KRT6A; KRT16; SERPINB5; TBX5;	GO:0002009~morphogenesis of an epithelium	4	17	23.5294117647059	0.0345985628648107	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	APOA1; APOC1; APOC3; APOA4;	GO:0034375~high-density lipoprotein particle remodeling	4	17	23.5294117647059	0.0345985628648107	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
up	LILRA5; IFNG; AIF1; LILRA2; TLR8;	GO:2000778~positive regulation of interleukin-6 secretion	5	37	13.5135135135135	0.0352090859076952	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
up	ACOD1; BMPR1B; NCR3; IL18RAP; LY86; CALCA; ORM1; CCL2; ALOX15; CD40LG; CNR2; IL13; CXCR3; AIF1; NLRP6; NLRP9; CD180; PROK2; PF4; PTGDR; CCL24; PF4V1; CCL7; CCL26; CCR5; IL2RA;	GO:0006954~inflammatory response	26	381	6.8241469816273	0.0354611862195466	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
up	NUAK1; FN1; CCL2; GP9; KITLG; CDH3; LAMA1; L1CAM; THBS2; GP5; CXCR3; CDH11; SRPX; SPOCK1; SLAMF1; LAMC2; ADGRE1; MYBPC3; COL19A1; POSTN; FEZ1; NTM; SIRPG; CD300A; CLEC4A; SIGLEC5; SIGLEC14; SIGLEC7; ICAM3; ICAM5;	GO:0007155~cell adhesion	30	454	6.6079295154185	0.0359227871054844	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
down	ATP1B1; S100A6; GJA1; ATP4A; CHRNA7; SCNN1A; SCNN1B; SCNN1G; GRIK2; GRIK3; FXYD3; ATP6V1C2; ATP6V0A4; ASIC5; CLCA3P; GABRG3; GABRD; GABRA4; HTR3B; HTR3A; GABRB2;	GO:0034220~ion transmembrane transport	21	208	10.0961538461538	0.0373024929167267	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
up	CCL24; CSF3; ALOX15; NCKAP1L; LMOD2; CCL26;	GO:0030838~positive regulation of actin filament polymerization	6	51	11.7647058823529	0.0375020709792092	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
up	IL2RA; FN1; PF4; FCER2; CSF3; CCL2; OSM; ALOX15; IL10; IL13; OPRM1; FASLG; CCR5; IL5RA; IRF4; IL31; IL31RA; IL26; IL20; IFNA5;	GO:0019221~cytokine-mediated signaling pathway	20	278	7.19424460431655	0.0389605740858799	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
down	IGF1; PDGFRA; SLURP1;	GO:0001775~cell activation	3	10	30	0.0396898823888963	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	APOA1; APOC3; APOA4;	GO:0034378~chylomicron assembly	3	10	30	0.0396898823888963	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	HOXD10; TFAP2B; TBX5;	GO:0035136~forelimb morphogenesis	3	10	30	0.0396898823888963	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	BMP5; TCF15; STRA6;	GO:0043583~ear development	3	10	30	0.0396898823888963	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	PSCA; PATE4; SLURP1;	GO:0099601~regulation of neurotransmitter receptor activity	3	10	30	0.0396898823888963	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
up	IFNG; CD40LG; IRF8; SCIMP;	GO:0032735~positive regulation of interleukin-12 production	4	26	15.3846153846154	0.0402076429897056	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
down	IL18; RAET1G; RAET1E; ULBP2;	GO:0042267~natural killer cell mediated cytotoxicity	4	18	22.2222222222222	0.0403290422528406	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	SLCO2B1; SLCO2A1; SLCO1C1; SLCO6A1;	GO:0043252~sodium-independent organic anion transport	4	18	22.2222222222222	0.0403290422528406	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	DES; KRT20; KRT17; TCHH;	GO:0045109~intermediate filament organization	4	18	22.2222222222222	0.0403290422528406	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	CCL1; S100A7; CXCL17; S100A14;	GO:0090026~positive regulation of monocyte chemotaxis	4	18	22.2222222222222	0.0403290422528406	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	PLA2G4E; TNFAIP8L3; PLA2G4F; PLA2G4D; PLA2G3; PLPPR1; PLA2G2F; PLA2G5;	GO:0006644~phospholipid metabolic process	8	57	14.0350877192982	0.0410241148946033	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
up	IFNG; IL2RA; CTLA4;	GO:0045589~regulation of regulatory T cell differentiation	3	15	20	0.0415208369491324	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
up	IFNG; FCER2; CCL2;	GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process	3	15	20	0.0415208369491324	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
down	UPK1A; TCF21; GSTA1; KRT3; KRT4; AKR1C2; DLX5; ELF3; DLX3;	GO:0030855~epithelial cell differentiation	9	68	13.2352941176471	0.0417597439980061	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
up	CALCA; GPR65; P2RY10; GPR174; GPR55;	GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	5	39	12.8205128205128	0.0418885259491576	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
down	CEACAM5; SELE; CBLN1; LGALS7; CADM3; NECTIN4; IGSF21;	GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	7	47	14.8936170212766	0.0425799553787712	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	TRABD2B; NOTUM; SOSTDC1; TSKU; DKK4; WIF1; NKD2;	GO:0030178~negative regulation of Wnt signaling pathway	7	47	14.8936170212766	0.0425799553787712	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	FGF1; PTN; FGF7; PROK1; MACC1; GAREM1; GKN1;	GO:0051781~positive regulation of cell division	7	47	14.8936170212766	0.0425799553787712	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	AGR2; PTN; FOXF1; VWC2; EGFLAM; NPNT;	GO:0010811~positive regulation of cell-substrate adhesion	6	37	16.2162162162162	0.0429565683521362	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
up	IFNG; IL13; AIF1; TLR8;	GO:0001774~microglial cell activation	4	27	14.8148148148148	0.0446230722440418	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
up	CDH26; CDH3; CDH11; CDH13;	GO:0044331~cell-cell adhesion mediated by cadherin	4	27	14.8148148148148	0.0446230722440418	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
up	IFNG; IL10; CLEC6A; IL26;	GO:0050715~positive regulation of cytokine secretion	4	27	14.8148148148148	0.0446230722440418	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
down	APOA4; NOS2; H2BFS; DEFB1;	GO:0002227~innate immune response in mucosa	4	19	21.0526315789474	0.0465646711044632	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	WNT9B; PDGFRA; BMP5; DHCR24;	GO:0030539~male genitalia development	4	19	21.0526315789474	0.0465646711044632	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	POMC; SAA1; GHR; MUC1; EDN2; PTPRZ1; IL12B; NOS2; CCL11; CX3CL1; LCN2; IL18; IL20RB; IL17REL; IL22RA1; IL1F10; IL22RA2; IL17F; CCL19; IL1RL2; DUOX2; IL36B; IL36G; IL36RN; IL36A; IL20RA;	GO:0019221~cytokine-mediated signaling pathway	26	278	9.35251798561151	0.0469095283043158	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
up	ALOX15; IL10; SKAP1;	GO:0034116~positive regulation of heterotypic cell-cell adhesion	3	16	18.75	0.0477504010413932	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
up	CALCA; NTRK1; ANO1;	GO:0050965~detection of temperature stimulus involved in sensory perception of pain	3	16	18.75	0.0477504010413932	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
down	FUT3; FUT2; FUT6;	GO:0036065~fucosylation	3	11	27.2727272727273	0.0483075225625321	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	PTN; MESP1; KDR;	GO:0045446~endothelial cell differentiation	3	11	27.2727272727273	0.0483075225625321	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
down	APOA4; GPIHBP1; APOA1;	GO:0051006~positive regulation of lipoprotein lipase activity	3	11	27.2727272727273	0.0483075225625321	0.578135064815517	1	1	0.999999778582005	0.999999778582005	1
up	F2; CALCB; CALCA; TRPC5; TRPC3;	GO:0051480~regulation of cytosolic calcium ion concentration	5	41	12.1951219512195	0.0492811336467658	0.613865510544982	1	1	0.999999999950212	0.999999999950211	1
